​A significant shift in pharmaceutical pricing Pfizer has announced a voluntary decision to reduce drug prices for Medicaid patients across the United States, marking a notable shift in how major pharmaceutical companies approach medication costs. The announcement came on September 30 and represents the company’s response to ongoing pressure from government officials and patient advocacy […] The post Pfizer’s exciting price cuts benefit patients appeared first on Rolling Out.